AI based platform that reduces cost of primary healthcare by upto 50%


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Fast Facts

Sevamob is a US-based company that provides an artificial intelligence-enabled healthcare platform to organizations in India and the US. Its two components are a) AI-based proprietary point-of-care screening for blood, vision, diet, urine and sputum; and b) Health outcome delivery via telehealth and asset-lite popup clinics. 

By integrating these components, we enable access to primary care at upto 50% reduced cost. It is monetized via software licensing and health outcome delivery. Our B2B customers include employers, NGOs, hospitals/clinics, pharma, health insurance and local governments.

Scarcity of Medical Professionals
& Diagnostic Services

Under-served areas have a scarcity of medical professionals and
diagnostic services.

For example, physician density in India is 0.7 compared to WHO recommended 1/1000, and in the rural areas of the US, it is 1.3 compared to 3.1 in urban areas around the US. This delays diagnosis and treatment and increases cost of care upto 2X due to the need for sample or patient transportation.

Easily Accessible Primary Healthcare
For Less

At Sevamob, we provide artificial intelligence enabled primary healthcare
platform to organizations.

It has two components:

Our Key Components

Our platform has two components.

Traction & Accomplishments

Product Development
Our technology platform timeline is as follows:

Customer Acceptance
We have 93+ B2B customers in 15+ states of India and 1 state of the US with a 90%+ renewal rate. Our gross margin is 28%

Our key customers include:

We have four patents pending in India.

Social Proof

We have partnerships with rapid diagnostic companies like Alere, medical device companies like Medtronic, and NGOs like Swasti. We have franchisees in southern Africa and central America

Meet the Team

CEO - Shelley Saxena
has managed several multi-million-dollar products for IBM and co-founded profitable mobile technology startup.


Sales - Shyam Tandon
has 34+ years of experience managing sales/marketing in FMCG like P&G and Glaxo.


Business development - Anthony Ponmany
has 20+ years experience managing sales in pharma like Abbott.


CTO - Vivek Mishra
has 14+ years experience as team lead and software developer for web, mobile, database and AI.


CMO Asia - Dr. Ankit Agrawal
has 10+ years of experience as a physician.


CMO USA - Dr. Darina Stankeyeva
is Board Certified in Internal Medicine and practices in Atlanta. She trained at Emory University.


The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.